ANTX
AN2 Therapeutics, Inc.
16.89
USD
This page is just a preview of the data found in TrendSpider’s full version
AN2 Therapeutics, Inc. stock is up 12.15% since 30 days ago. The next earnings date is Mar 27, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 1 December’s closed higher than November.
AN2 Therapeutics is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.
